Dr. Reddy's Laboratories Limited
Price Action
Technical Summary
DOWNTRENDDr. Reddy's Laboratories Limited is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 40), showing significant lag compared to the market leaders. Earnings contraction of 14% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $13.37 | +0.68% | ABOVE |
| 50 SMA | $13.72 | -1.91% | BELOW |
| 100 SMA | $13.80 | -2.45% | BELOW |
| 150 SMA | $13.87 | -2.95% | BELOW |
| 200 SMA | $13.98 | -3.69% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RDY in an uptrend right now?
RDY has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is RDY overbought or oversold?
RDY's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.
Is RDY outperforming the market?
RDY has a Relative Strength (RS) Rating of 40 out of 99. RDY is currently lagging the broader market.
Where is RDY in its 52-week range?
RDY is trading at $13.46, which is 83% of its 52-week high ($16.17) and 20% above its 52-week low ($12.77).
How volatile is RDY?
RDY has a Beta of 0.46 and 52-week volatility of 23%. It's less volatile than the S&P 500 - generally more stable.